Who is the CEO of ALT? | Glauxie AI

Q: Who is the CEO of ALT?

Altimmune, Inc. (ALT) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Jerome Benedict Durso. Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly... Employees: 57.

Q: What does ALT company do?

Learn what ALT does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling ALT?

Track recent insider buys and sells for ALT with transaction details, amounts, and trends.

Q: What sector is ALT in?

Find ALT sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of ALT?

🦉

Altimmune, Inc. (ALT)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJerome Benedict Durso

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the...

Key Executives

Name	Title
Andrew Shutterly	Principal Financial & Accounting Officer and Corporate Controller
Bertrand Georges	Chief Technology Officer
Christophe Arbet-Engels	Chief Medical Officer
Gregory L. Weaver	Chief Financial Officer
Jerome Benedict Durso	Chairman, CEO & President
Linda Richardson	Chief Commercial Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ALT Profile Financials

What does ALT company do? Are insiders buying or selling ALT? What sector is ALT in?